Concordance between tumor proportion score (TPS) and combined positive score (CPS) for PD-L1 expression in esophageal squamous cell carcinoma: a structured narrative review
Cancer Treatment and Research Communications · 2026 · 49 · 101480
DOI: 10.1016/j.ctarc.2026.101480 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Raquel P Saraiva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Instituto Português de Oncologia Francisco Gentil de Coimbra, Portugal. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
INTRODUCTION: Advanced esophageal cancer benefits from immunotherapy. For squamous cell carcinoma (SCC), allocation for immune checkpoint inhibitors (ICI) is based on PD-L1 positivity assessed by the tumor proportion score (TPS) and combined positive score (CPS). It is unclear whether patients without an indication for ICI based on TPS are eligible when CPS is considered, or vice versa. METHODS: A systematic literature search in Medline, Embase, Web of Science, and Cochrane was conducted to identify studies evaluating PD-L1 expression using TPS and CPS in esophageal SCC. PD-L1 discordant cases were defined as TPS
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Instituto Português de Oncologia Francisco Gentil de Coimbra, Portugal.
- Department of Medical Oncology, Erasmus MC Cancer Institute University Medical Center, Rotterdam, the Netherlands. Electronic address: t.j.huizer@erasmusmc.nl.
- Department of Surgery, Erasmus MC Cancer Institute University Medical Center, Rotterdam, the Netherlands.
- Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.
- Department of Medical Oncology, Erasmus MC Cancer Institute University Medical Center, Rotterdam, the Netherlands.
Zitieren
APA
Saraiva, R. P., Huizer, T. J., Wijnhoven, B. P. L., Lagarde, S. M., Oudijk, L., & Mostert, B. (2026). Concordance between tumor proportion score (TPS) and combined positive score (CPS) for PD-L1 expression in esophageal squamous cell carcinoma: a structured narrative review. Cancer Treatment and Research Communications, 49, 101480. https://doi.org/10.1016/j.ctarc.2026.101480
Vancouver
Saraiva RP, Huizer TJ, Wijnhoven BPL, Lagarde SM, Oudijk L, Mostert B. Concordance between tumor proportion score (TPS) and combined positive score (CPS) for PD-L1 expression in esophageal squamous cell carcinoma: a structured narrative review. Cancer Treatment and Research Communications. 2026;49:101480. doi:10.1016/j.ctarc.2026.101480
BibTeX
@article{Saraiva2026,
author = {Saraiva, Raquel P and Huizer, Tamara J and Wijnhoven, Bas P L and Lagarde, Sjoerd M and Oudijk, Lindsey and Mostert, Bianca},
title = {Concordance between tumor proportion score (TPS) and combined positive score (CPS) for PD-L1 expression in esophageal squamous cell carcinoma: a structured narrative review},
journal = {Cancer Treatment and Research Communications},
year = {2026},
volume = {49},
pages = {101480},
doi = {10.1016/j.ctarc.2026.101480}
}
EUVIMED